Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Metrics to compare | NICA | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipNICAPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.3x | −9.6x | −0.5x | |
PEG Ratio | −0.04 | −0.20 | 0.00 | |
Price/Book | 2.7x | 6.6x | 2.6x | |
Price / LTM Sales | 6.8x | 42.3x | 3.3x | |
Upside (Analyst Target) | 97.4% | 11.7% | 43.5% | |
Fair Value Upside | Unlock | 7.7% | 6.9% | Unlock |